
{"id":63,"date":"2015-01-19T13:56:45","date_gmt":"2015-01-19T13:56:45","guid":{"rendered":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/?page_id=63"},"modified":"2026-01-07T11:36:09","modified_gmt":"2026-01-07T11:36:09","slug":"disciplinas","status":"publish","type":"page","link":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/disciplinas\/","title":{"rendered":"Disciplinas"},"content":{"rendered":"<ul>\n<li><a href=\"http:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-content\/uploads\/sites\/16\/2026\/01\/Quadro-de-Oferta-2026-1-MMolecular.pdf\">Acesse aqui as disciplinas ofertadas 2026\/1\u00ba<\/a><\/li>\n<\/ul>\n<p>[otw_shortcode_content_toggle title=&#8221;\u00a0MED182 &#8211; Farmacocin\u00e9tica&#8221; opened=&#8221;closed&#8221;]Ementa:\u00a0Estudos sobre absor\u00e7\u00e3o, distribui\u00e7\u00e3o, elimina\u00e7\u00e3o de medicamentos e determina\u00e7\u00e3o dos principais par\u00e2metros farmacocin\u00e9ticos \u00fateis, dentre outras, as seguintes finalidades: a) Estabelecimento de regimes posol\u00f3gicos adequados; b) Avalia\u00e7\u00e3o das possibilidades de utiliza\u00e7\u00e3o pr\u00e1tica para medicamentos rec\u00e9m obtidos. Conceitos atuais de farmacogen\u00e9tica e farmacogen\u00f4mica.<br \/>\n<strong>Bibliografia:<\/strong><br \/>\nDeenen MJ, Cats A, Beijnen JH, Schellens JH (2011) Part 1: backgroung, methodology, and clinical adoption of pharmacogenetics. Oncologist 16:811-819<br \/>\nDeenen MJ, Cats A, Beijnen JH, Schellens JH (2011) Part 2: pharmacogenetic variability in drug transport and phase i anticancer drug metabolism. Oncologist 16:820-834<br \/>\nHuston A, Arrowsmith CH, Knapp S, Schapira M (2015) Probing the epigenome. Nat Chem Biol 11: 542-545<br \/>\nJameson JL, Longo DL (2015) Precision medicine&#8211;personalized, problematic, and promising. N Engl J Med 372:2229-2234<br \/>\nJ\u00f8rgensen JT (2015) Clinical application of companion diagnostics. Trends Mol Med. 21: 405-407<br \/>\nLeBlanc TW, McNeil MJ, Kamal AH, Currow DC, Abernethy AP (2015) Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol 16: e333-e341<br \/>\nMuller F, Fromm MF (2011) Transporter-mediated drug-drug interactions. Pharmacogenomics 12:1017-1037<br \/>\nRowland M, Tozer TN (2010) Pharmacokinetics and Pharmacodynamics: Concepts and Applications. Lippincott Williams &amp; Wilkins; 4\u00aa edi\u00e7\u00e3o<br \/>\nSam AT, Lian Jessica LL, Parasuraman S (2015) A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors. J Basic Clin Pharm 6: 64-68<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED815 &#8211; Farmacologia da comunica\u00e7\u00e3o e sinaliza\u00e7\u00e3o celular&#8221; opened=&#8221;closed&#8221;]Ementa: Discuss\u00e3o dos conceitos b\u00e1sicos relacionados \u00e0 sinaliza\u00e7\u00e3o inter e intracelular, tais como intera\u00e7\u00e3o f\u00e1rmaco-receptor,receptores acoplados a canais i\u00f4nicos ou \u00e0 prote\u00edna G, regula\u00e7\u00e3o porfosforila\u00e7\u00e3o, cascatas de quinases, etc. Uma vez assimilados os conceitos b\u00e1sicos, os estudantes apresentar\u00e3o semin\u00e1rios de trabalhos recentes a serem discutidos pelo grupo.<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Anastas JN (2015) Functional crosstalk between WNT signaling and tyrosine kinase signaling in cancer. Semin Oncol 42: 820-831<\/p>\n<p>Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, Hunter T, Brognard J, Newton AC (2015) Cancer-associated protein kinase C mutations reveal kinase&#8217;s role as tumor suppressor. Cell 160: 489-502<\/p>\n<p>Atlas D (2014) Voltage-gated calcium channels function as Ca2+-activated signaling receptors. Trends Biochem Sci 39: 45-52<\/p>\n<p>Fiskus W, Mitsiades N (2016) B-Raf Inhibition in the Clinic: Present and Future. Annu Rev Med 67: 29-43<\/p>\n<p>Johnson DB, Pollack MH, Sosman JA (2016) Emerging targeted therapies for melanoma. Expert Opin Emerg Drugs 21: 195-207<\/p>\n<p>Stanley EF (2016) The nanophysiology of fast transmitter release. Trends Neurosci 39: 183-197<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;\u00a0MED816 &#8211; Farmacologia da neurotransmiss\u00e3o colin\u00e9rgica&#8221; opened=&#8221;closed&#8221;]Ementa:Aulas te\u00f3ricas: 1) Organiza\u00e7\u00e3o da sinapse colin\u00e9rgica. 2) Controle da s\u00edntese e libera\u00e7\u00e3o de acetilcolina. 3) Teoria vesicular da libera\u00e7\u00e3o de acetilcolina. 4) Teoria citoplasm\u00e1tica da libera\u00e7\u00e3o de acetilcolina. 5) Receptor muscar\u00ednico e metabolismo de inositol fosfatos. 6) Fosforila\u00e7\u00e3o de prote\u00ednas e libera\u00e7\u00e3o de neurotransmissores. Aulas Pr\u00e1ticas: 1) Prepara\u00e7\u00e3o de fatias de c\u00f3rtex cerebral para experimentos de libera\u00e7\u00e3o de acetilcolina. 2) Dosagem de acetilcolina: m\u00e9todos radioativo e quimiluminesc\u00eante. 3) Prepara\u00e7\u00e3o da fra\u00e7\u00e3o sinaptosomal.<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Dunkley PR (1988) A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res 441: 59-71<\/p>\n<p>Guzman MS, De Jaeger X, Raulic S, Souza IA, Li AX, Schmid S, Menon RS, Gainetdinov RR, Caron MG, Bartha R, Prado VF, Prado MA (2011) Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol 9:e1001194<\/p>\n<p>Kavalali ET (2015) The mechanisms and functions of spontaneous neurotransmitter release. Nat Rev Neurosci 16: 5-16<\/p>\n<p>Kolisnyk B, Al-Onaizi MA, Xu J, Parfitt GM, Ostapchenko VG, Hanin G, Soreq H, Prado MA, Prado VF (2016) Cholinergic regulation of hnRNPA2\/B1 translation by M1 muscarinic receptors. J Neurosci 36: 6287-6296<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED813 &#8211; Medicina molecular I&#8221; opened=&#8221;closed&#8221;]Ementa: Estudo dos conceitos gerais de bioqu\u00edmica, biologia molecular e gen\u00e9tica<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Ausubel FM (2002) Short Protocols in Molecular Biology, Canad\u00e1, Wiley<\/p>\n<p>Bunnik EM (2015) Do genomic tests enhance autonomy? J Med Ethics 41: 315-316<\/p>\n<p>Campbell JD, Mazzilli SA, Reid ME, Dhillon SS, Platero S, Beane J, Spira AE (2016) The case for a Pre-Cancer Genome Atlas (PCGA). Cancer Prev Res 9: 119-124<\/p>\n<p>Cirulli ET (2016) The increasing importance of gene-based analyses. PLoS Genet 12: e1005852<\/p>\n<p>Erden A (2015) Personalized Medicine: how studying individual differences can shed light on treating thousands of patients: an interview with Richard Lifton, PhD. Yale J Biol Med 88: 407-411<\/p>\n<p>Kurpinski K, Johnson T, Kumar S, Desai T, Li S (2014) Mastering translational medicine: interdisciplinary education for a new generation. Sci Transl Med 6: 218fs<\/p>\n<p>Lelieveld SH, Veltman JA, Gilissen C (2016) Novel bioinformatic developments for exome sequencing. Hum Genet 135: 603-614<\/p>\n<p>Niroula A, Vihinen M (2016) Variation interpretation predictors: principles, types, performance, and choice. Hum Mutat 37: 579-597<\/p>\n<p>Servick K (2015) Can 23andMe have it all? Science 349: 1472-474, 1476-1477<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED814 &#8211; Medicina molecular II&#8221; opened=&#8221;closed&#8221;]Ementa:\u00a0Utiliza\u00e7\u00e3o de t\u00e9cnicas de biologia celular e molecular. Semin\u00e1rios sobre o potencial uso dessas t\u00e9cnicas no entendimento da fisiopatologia das doen\u00e7as e suas implica\u00e7\u00f5es terap\u00eauticas.<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Alix-Panabi\u00e8res C, Pantel K (2016) Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov 6: 479-491<\/p>\n<p>Frank M (2003) Impact factors: arbiter of excellence? J Med Libr Assoc 91: 4-6<\/p>\n<p>Frank M (2013) Open but not free &#8211; publishing in the 21st century. N Engl J Med 368:787-789<\/p>\n<p>Goodwin S, McPherson JD, McCombie WR (2016) Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet 17: 333-351<\/p>\n<p>Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8: 2281-2308<\/p>\n<p>Shain AH, Bastian BC (2016) From melanocytes to melanomas. Nat Rev Cancer 16: 345-358<\/p>\n<p>Twa DD, Squair JW, Skinnider MA, Ji JX (2015) The Canadian clinician-scientist training program must be reinstated. J Clin Invest 125: 4317-4319<\/p>\n<p>Vissers LE, Gilissen C, Veltman JA (2016) Genetic studies in intellectual disability and related disorders. Nat Rev Genet 17: 9-18<\/p>\n<p>Vogelstein B, Kinzler KW (2015) The path to cancer &#8212; three strikes and you&#8217;re out. N Engl J Med 373: 1895-1898<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED817\u00a0&#8211;\u00a0M\u00e9todos de laborat\u00f3rio &#8221; opened=&#8221;closed&#8221;]Ementa: A disciplina visa introduzir aos alunos conceitos b\u00e1sicos sobre t\u00e9cnicas rotineiramente utilizadas em laborat\u00f3rios de pesquisa. Desse modo, ser\u00e3o enfocadas aulas pr\u00e1ticas e te\u00f3ricas de: pesagem, aferi\u00e7\u00e3o e calibra\u00e7\u00e3o de material volum\u00e9trico, titulometria, colorimetria, centrifuga\u00e7\u00e3o e fracionamento celular, cromatografia, fluorometria.<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>de Duve C (1971) Tissue fractionation: past and present. J Cell Biol 50:20D-55D<\/p>\n<p>Kolthoff IM, Sandell EB. Textbook of quantitative inorganic analysis. MacMillan, New York<\/p>\n<p>Nicholls D (1994) Proteins, transmitters and synapses. Blackwell Scientific. 1st edition.<\/p>\n<p>Snell FD, Snell CT. Colorimetric methods od analysis. Volume IV A. van Wostrand Reinhold Co, New York<\/p>\n<p>Braga GL,Collins CH. Introdu\u00e7\u00e3o a M\u00e9todos Cromatogr\u00e1ficos. Ed. Unicamp, Campinas<\/p>\n<p>Stalil E. Thin Layer Chromatography. Spring Verlag, Amsterdam<\/p>\n<p>Turner AJ, Bachelard HS (1997) Neurochemistry a practical approach. Oxford University Press, 2nd edition<\/p>\n<p>Wilson K, Goulding K (1986) A biologist\u2019s guide to principles and techniques of practical biochemistry. E. Arnold. 3rd edition<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED819 &#8211; Semin\u00e1rios de pesquisa I&#8221; opened=&#8221;closed&#8221;]Ementa:\u00a0Participa\u00e7\u00e3o em discuss\u00f5es cr\u00edticas sobre trabalhos que est\u00e3o sendo realizados ou outros de relev\u00e2ncia. Semin\u00e1rios dos alunos de P\u00f3s-Gradua\u00e7\u00e3o, com a presen\u00e7a dos docentes do Programa, professores visitantes ou especialistas de alto n\u00edvel<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Variada. Inclui artigos dos peri\u00f3dicos American Journal of Human Genetics, American Journal of Psychiatry, Cancer Epidemiology and Biomarkers, Cell, Clinical Cancer Research, Journal of Clinical Investigation, Molecular Psychiatry, Nature, Nature Genetics, Nature Medicine, Nature Neuroscience, Nature Reviews, New England Journal of Medicine, Science, Science Translational Medicine, etc.<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED820\u00a0&#8211; Semin\u00e1rios de pesquisa II&#8221; opened=&#8221;closed&#8221;]Ementa:Prepara\u00e7\u00e3o para a doc\u00eancia, a qualifica\u00e7\u00e3o do ensino de gradua\u00e7\u00e3o, compat\u00edveis com a \u00e1rea de pesquisa no programa de p\u00f3s-gradua\u00e7\u00e3o, realizada pelo p\u00f3s-graduando, de acordo com a Portaria n\u00ba 64, de 18 de novembro 2002, da CAPES<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Variada.<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n<p>[otw_shortcode_content_toggle title=&#8221;MED821 &#8211; T\u00f3picos avan\u00e7ados em medicina molecular &#8221; opened=&#8221;closed&#8221;]Ementa:\u00a0Semin\u00e1rios abordando conhecimentos adquiridos recentemente sobre t\u00f3picos relevantes de Medicina Molecular ou disciplinas afins e\/ou curso pr\u00e1tico sobre m\u00e9todos atuais aplic\u00e1veis \u00e0s condi\u00e7\u00f5es locais, e que possibilitem abordagem de quest\u00f5es cient\u00edficas importantes, de interesse de professores e alunos do programa de p\u00f3s-gradua\u00e7\u00e3o<\/p>\n<p><strong>Bibliografia:<\/strong><\/p>\n<p>Variada; distribuida no inicio do semestre letivo.<\/p>\n<p>[\/otw_shortcode_content_toggle]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Acesse aqui as disciplinas ofertadas 2026\/1\u00ba [otw_shortcode_content_toggle title=&#8221;\u00a0MED182 &#8211; Farmacocin\u00e9tica&#8221; opened=&#8221;closed&#8221;]Ementa:\u00a0Estudos sobre absor\u00e7\u00e3o, distribui\u00e7\u00e3o, elimina\u00e7\u00e3o de medicamentos e determina\u00e7\u00e3o dos principais par\u00e2metros farmacocin\u00e9ticos \u00fateis, dentre outras, as seguintes finalidades: a) Estabelecimento de regimes posol\u00f3gicos adequados; b) Avalia\u00e7\u00e3o das possibilidades de utiliza\u00e7\u00e3o pr\u00e1tica para medicamentos rec\u00e9m obtidos. Conceitos atuais de farmacogen\u00e9tica e farmacogen\u00f4mica. Bibliografia: Deenen MJ, [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-63","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/pages\/63","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/comments?post=63"}],"version-history":[{"count":20,"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/pages\/63\/revisions"}],"predecessor-version":[{"id":1151,"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/pages\/63\/revisions\/1151"}],"wp:attachment":[{"href":"https:\/\/www.medicina.ufmg.br\/cpgmedicinamolecular\/wp-json\/wp\/v2\/media?parent=63"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}